Literature DB >> 17006632

Intravenous immunoglobulins in paraneoplastic brainstem encephalitis with anti-Ri antibodies.

Arnaud Fumal, Jerome Jobe, Jean-Louis Pepin, Valerie Delvaux, Jean-Marc Senterre, Sandrine Bonaventure, Alain Maertens de Noordhout.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 17006632     DOI： 10.1007/s00415-006-0199-7

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Paraneoplastic brainstem encephalitis with tetraparesis in a patient with anti-Ri antibodies.

Authors:  Y A Rajabally; S Naz; D Farrell; R J Abbott
Journal:  J Neurol       Date:  2004-12       Impact factor: 4.849

2.  Intravenous immunoglobulin treatment in paraneoplastic neurological syndromes with antineuronal autoantibodies.

Authors:  M Uchuya; F Graus; F Vega; R Reñé; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

3.  Intravenous immunoglobulins in the therapy of paraneoplastic neurological disorders.

Authors:  F Blaes; M Strittmatter; S Merkelbach; V Jost; M Klotz; K Schimrigk; G F Hamann
Journal:  J Neurol       Date:  1999-04       Impact factor: 4.849

4.  Anti-Ri: an antibody associated with paraneoplastic opsoclonus and breast cancer.

Authors:  F A Luque; H M Furneaux; R Ferziger; M K Rosenblum; S H Wray; S C Schold; M J Glantz; K A Jaeckle; H Biran; M Lesser
Journal:  Ann Neurol       Date:  1991-03       Impact factor: 10.422

5.  Treatment of paraneoplastic neurological syndromes with antineuronal antibodies (Anti-Hu, anti-Yo) with a combination of immunoglobulins, cyclophosphamide, and methylprednisolone.

Authors:  F Keime-Guibert; F Graus; A Fleury; R René; J Honnorat; P Broet; J Y Delattre
Journal:  J Neurol Neurosurg Psychiatry       Date:  2000-04       Impact factor: 10.154

6.  Anti-neuronal nuclear autoantibody type 2: paraneoplastic accompaniments.

Authors:  Sean J Pittock; Claudia F Lucchinetti; Vanda A Lennon
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 7.  Paraneoplastic neurological syndromes: an update on diagnosis, pathogenesis, and therapy.

Authors:  Raymond Voltz
Journal:  Lancet Neurol       Date:  2002-09       Impact factor: 44.182

8.  Therapy for paraneoplastic neurologic syndromes in six patients with protein A column immunoadsorption.

Authors:  L M Cher; F H Hochberg; J Teruya; M Nitschke; R F Valenzuela; J D Schmahmann; M Herbert; H D Rosas; C Stowell
Journal:  Cancer       Date:  1995-04-01       Impact factor: 6.860

9.  Paraneoplastic cerebellar degeneration associated with antineuronal antibodies: analysis of 50 patients.

Authors:  Setareh Shams'ili; Joost Grefkens; Bertie de Leeuw; Martin van den Bent; Herbert Hooijkaas; Bronno van der Holt; Charles Vecht; Peter Sillevis Smitt
Journal:  Brain       Date:  2003-06       Impact factor: 13.501

10.  An antineuronal autoantibody in paraneoplastic opsoclonus.

Authors:  C Budde-Steffen; N E Anderson; M K Rosenblum; F Graus; D Ford; B J Synek; S H Wray; J B Posner
Journal:  Ann Neurol       Date:  1988-05       Impact factor: 10.422
View more
  2 in total

Review 1.  [Administration of intravenous immunoglobulins in neurology. An evidence-based consensus: update 2010].

Authors:  M Stangel; R Gold
Journal:  Nervenarzt       Date:  2011-04       Impact factor: 1.214

2.  Encephalitis with herpes simplex-2 in the cerebrospinal fluid and anti-RI (ANNA-2) antibodies: an infectious or a paraneoplastic syndrome?

Authors:  Jan Novy; Antonio Carota; Philippe Eggimann; Marc Pusztaszeri; Andrea O Rossetti; Renaud Du Pasquier
Journal:  BMJ Case Rep       Date:  2009-08-11
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.